How I treat adverse effects of CAR-T cell therapy

Chimeric antigenreceptor (CAR) T cell therapy has demonstrated efficacy in B cell malignancies, particularly for acute lymphoblastic leukaemia (ALL) and non‑Hodgkin lymphomas. However, this regimen is not harmless and, in some patients, can lead to a multi organ failure. For this reason, the knowled...

Descripción completa

Detalles Bibliográficos
Autores principales: Yáñez, Lucrecia, Alarcón, Ana, Sánchez-Escamilla, Miriam, Perales, Miguel-Angel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7451454/
https://www.ncbi.nlm.nih.gov/pubmed/32839196
http://dx.doi.org/10.1136/esmoopen-2020-000746

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7451454/
https://www.ncbi.nlm.nih.gov/pubmed/32839196
http://dx.doi.org/10.1136/esmoopen-2020-000746

Ejemplares similares